Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seretide Diskus with or without compliance enhancement training in asthma
2005-000374-48Phase 4Completed
- Sponsor
- GSK
- Start
- Apr 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of salmeterol + fluticasone in asthma (2 arms), sponsored by GSK. Primary endpoint: Total control in treatment period 2. Started Apr 2005; status: completed.
02
Drugs
salmeterol + fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on 2005-000374-48.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000374-48.